Health in Cape Verde 960 indicators covering health for Cape Verde. IndicatorLatest Year10-yr change Rank Mean total cholesterol, age-standardized 4.1 2018 up 2.5% 151st Prevalence of anemia among children 44.1% 2019 down 13.4% 54th Births attended by skilled health staff 97.3% 2018 up 30.4% 93rd Births attended by health staff sdgs 97.3 2018 up 30.4% 93rd Number of deaths among children ages 10 to 14 years 11 2021 down 35.3% 161st Adolescent mortality rate 0.9794 2021 down 34.4% 126th Adults (ages 15+) living with HIV 3,800 2024 up 40.7% 117th Prevalence of current tobacco use 10.4% 2024 down 21.8% 131st Prevalence of current tobacco use, females 4.9% 2024 down 29.0% 92nd Prevalence of current tobacco use, males 15.9% 2024 down 18.9% 130th BCG immunization coverage among 1-year-olds (%) 99.0% 2025 up 5.3% 1st Physicians per 1000 people 0.73 2023 up 21.5% 130th Physicians 0.73 per 1,000 people 2023 up 21.5% 130th Share of the population infected with hiv 0.9155 2024 up 21.2% 45th Global vaccination coverage 93 2024 down 2.1% 73rd Proportion of population with primary reliance on clean fuels and tech 63.0% 2024 up 70.3% 116th Incidence of tuberculosis 47 2024 down 42.0% 95th Number of incident tuberculosis cases 250 2024 down 40.5% 152nd Tuberculosis deaths by hiv status 6 2024 down 53.8% 123rd Tuberculosis case fatality rate 12 2024 up 50.0% 81st Number of incident tuberculosis cases 20 2024 down 48.7% 124th Number of deaths due to tuberculosis, excluding HIV 24 2024 up 9.1% 146th Deaths due to tuberculosis among HIV-negative people 4.6 2024 up 7.0% 84th Incidence of tuberculosis sdgs 47 2024 down 42.0% 97th Tuberculosis deaths region 30 2024 down 11.8% 141st Tuberculosis death rate 5.7 2024 down 14.9% 86th Tuberculosis deaths who 30 2024 down 11.8% 141st Tuberculosis patients with hiv share 8 2024 down 14.0% 57th Prevalence of hiv percentage of males and females ages 15 24 infected 0.1 2024 unchanged 70th Adults (ages 15+) and children (ages 0-14) newly infected with HIV 500 2024 unchanged 91st Tuberculosis - new and relapse cases 176 2024 down 35.8% 154th Tuberculosis treatment coverage 71 2024 up 7.6% 114th AIDS estimated deaths 100 UNAIDS estimates 2024 unchanged 98th Mean BMI (kg/mΒ²) 24.5 2016 up 2.5% 130th Rubella - number of reported cases 0 2025 β 91st Treatment success rate: new TB cases 55 2023 down 37.5% 177th Yellow fever - number of reported cases 0 2025 β 26th Current health expenditure per capita, PPP 616.54 current international $ 2023 up 100.7% 122nd Out-of-pocket expenditure per capita, PPP 158.7 current international $ 2023 up 113.0% 124th Domestic general government health expenditure 3.4% 2023 up 22.9% 87th Domestic private health expenditure per capita, PPP 187.62 current international $ 2023 up 126.6% 132nd Share of out of pocket expenditure on healthcare 25.74 2023 up 6.1% 110th Domestic general government health expenditure per capita 169.94 current US$ 2023 up 53.9% 108th Tuberculosis treatment success rate in new and relapsed cases 55 2023 down 37.5% 186th Private health expenditure per person 187.62 2023 up 126.6% 132nd Public healthcare spending share gdp 3.43 2023 up 22.9% 87th Health spending per person by source 361.13 2023 up 103.5% 115th Share of public expenditure on healthcare by country 58.57 2023 up 1.4% 90th Poliomyelitis - number of reported cases 0 2018 β 8th Number of new hiv infections per year 214.38 2024 up 4.2% 106th Rubella vaccination coverage 95 2024 up 20.3% 61st Deaths from aids un 60.88 2024 up 8.6% 105th Mortality rate among children ages 10 to 14 years 1 2020 down 35.7% 126th Cost healthy diet 3.81 2024 up 20.6% 131st Medical doctors 381 2023 up 23.7% 165th Adults (ages 15-49) newly infected with HIV 200 2024 unchanged 103rd People with basic handwashing facilities including soap and water 60.9% 2024 up 1.2% 68th Number of new hiv child infections vs number of infections averted due 12.6 2024 down 25.0% 78th Mean systolic blood pressure 129.2 2015 down 1.2% 20th UHC Service Coverage sub-index on infectious diseases 83 2023 up 25.8% 125th β Previous Page 9 of 16 Next β